Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY: CVS )

59.06 +0.70 (+1.20%)
Official Closing Price Updated: 4:10 PM EDT, Jun 28, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 13,972,335
Open 59.00
Bid (Size) 59.09 (1)
Ask (Size) 59.14 (1)
Prev. Close 58.36
Today's Range 58.47 - 59.98
52wk Range 52.77 - 83.25
Shares Outstanding 1,319,574,744
Dividend Yield 4.10%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Beaten-Down Stocks Ready for a Comeback: June 2024
Discover why these beaten-down stocks resurgence despite recent challenges, and explore their fundamentals in healthcare and broadcasting. 
Via InvestorPlace
The 3 Smartest Healthcare Stocks to Buy With $1K Right Now
The healthcare stocks to buy deserve more respect from investors who seek top-level growth outside of the tech sector. 
Via InvestorPlace

Performance

YTD
-26.95%
-26.95%
1 Month
+10.12%
+10.12%
3 Month
-25.95%
-25.95%
6 Month
-25.21%
-25.21%
1 Year
-13.33%
-13.33%

More News

Read More
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 3% Dividend Yields
Via Benzinga
Drug Distributor Cencora Falls; Blame Walgreens, Not The Supreme Court
Via Investor's Business Daily
Walgreens Plans 'Significant' Store Closures As It Faces 'Difficult Operating Environment'
Via Benzinga
Behind the Scenes of CVS Health's Latest Options Trends
Via Benzinga
CVS Health's Options Frenzy: What You Need to Know
Via Benzinga
Stock Of The Day: It's No Coincidence CVS Health Stock Found Support Where It Did
Via Benzinga
Bargain Alert: 7 Long-Term Stocks to Buy Hand-Over-Fist
Via InvestorPlace
Why Is Moderna Stock Trading Lower On Wednesday?
Via Benzinga
Exposures COVID-19
Investors Worry How Trump Tariffs Could Further Impact Companies Reliant On Chinese Suppliers: Vulnerable Stocks 'Have Underperformed' This Year
Via Benzinga
Topics Government World Trade
Exposures Political Tariff
Judge Rules Against MedImpact In $200M Rite Aid Debt Dispute
Via Benzinga
Topics Bankruptcy
Exposures Financial Legal
US Election And Tariff Prospects Set To Threaten Internationally-Exposed Stocks, Goldman Sachs Warns
Via Benzinga
Topics Government
Exposures Political
Vice President Kamala Harris Courts Corporate Leaders Amidst Tight Biden-Trump Race: Report
Via Benzinga
3 Must-Buy Stocks for Long-Term Gains: June 2024
Via InvestorPlace
7 At Risk Dividend Stocks Investors Should Sell Before It’s Too Late
Via InvestorPlace
Amazon Expands RxPass To Medicare Members: A Closer Look At Savings
Via Benzinga
Bear Of The Day: CVS Health
Via Talk Markets
3 High-Yield S&P 500 Dividend Stocks Down More Than 25% to Buy Now and Hold for at Least a Decade
Via The Motley Fool
Topics Stocks
Exposures US Equities
CVS ALERT: Bragar Eagel & Squire, P.C. is Investigating CVS Health Corporation on Behalf of CVS Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Maximize Profits with These 3 Discounted Stocks Set to Skyrocket
Via InvestorPlace
Is CVS Health Stock a Millionaire Maker?
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Top 3 Bargain Stocks to Watch Near Their 52-Week Low Prices
Via MarketBeat
Topics Economy
Exposures COVID-19 Economy Interest Rates
AbbVie's Arthritis Drug Humira Retains Market Dominance Despite Biosimilar Competition, Challenges Biosimilar Industry Viability
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.